Clinical Trials Logo

Clinical Trial Summary

This study is a prospective, open-label, multi-center, registry study, designed to to documents that EmboTrap II usage as a thrombectomy device for emergency large vessel occlusion (ELVO) in terms of the rate of First Pass Recanalization (FPR). Patients with ELVO will initially underwent mechanical thrombectomy usig EmboTrap II. FPR is defined as modified Tissue Thrombolysis In Cerebral Ischemia (mTICI) 2b or 3


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04310306
Study type Observational [Patient Registry]
Source Yonsei University
Contact Byung Moon Kim, PhD
Phone 82-2-2228-2399
Email bmoon21@yuhs.ac
Status Recruiting
Phase
Start date February 10, 2020
Completion date December 30, 2021